To include your compound in the COVID-19 Resource Center, submit it here.

Carfilzomib: Phase II data

A Phase II trial in 74 patients showed that carfilzomib plus dexamethasone led to a complete response (CR)/near

Read the full 184 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE